Today: 7 February 2026
Subscribe

Legend Biotech stock hits a fresh 52-week low as biotech lags — JPMorgan update looms

Legend Biotech stock hits a fresh 52-week low as biotech lags — JPMorgan update looms

New York, January 5, 2026, 15:53 EST — Regular session Legend Biotech Corp (LEGN) shares fell 4.7% to $20.49 on Monday, after touching $20.29 — a fresh 52-week low — in afternoon trading. The stock is about 55% below its 52-week high of $45.30. SoFi Money rotated into energy and bank stocks on Monday, lifting Wall Street’s main indexes, after a U.S. military strike captured Venezuelan President Nicolas Maduro. “Energy stocks are really benefiting from the expectation that President Trump is intending to send them in,” said Rob Haworth, senior investment strategist at U.S. Bank Wealth Management. Data showed U.S.
5 January 2026
····
Immunome (IMNM) stock drops 5% as biotech slips; investors look to Jan. 14 update

Immunome (IMNM) stock drops 5% as biotech slips; investors look to Jan. 14 update

NEW YORK, Jan 5, 2026, 15:54 EST — Regular session Shares of Immunome, Inc. fell 5.3% to $19.72 in late afternoon trading on Monday, underperforming U.S. biotech peers. The SPDR S&P Biotech ETF slid 1.1% and the iShares Nasdaq Biotechnology ETF was off 0.9%. IMNM opened at $20.83 and touched $19.36, with about 1.6 million shares changing hands by 3:54 p.m. EST, according to market data. Immunome has not posted a news release since Dec. 16, when it priced a public offering of common stock, the company’s investor relations site showed. That quiet calendar can magnify day-to-day swings in small-cap
5 January 2026
·····
Sanmina stock slides after early pop as manufacturing data, peer moves hit sentiment

Sanmina stock slides after early pop as manufacturing data, peer moves hit sentiment

New York, January 5, 2026, 15:37 EST — Regular session Sanmina Corp (SANM.O) shares fell 5.1% to $151.12 in afternoon trading on Monday after the contract manufacturer gave up an early rally that pushed the stock above $165. The stock opened at $164.72 and later touched a session low of $150.37. The slide left Sanmina lagging even as Wall Street rallied, with the Dow pushing to a record high on gains in financial and energy stocks. Investors were positioning ahead of Friday’s nonfarm payrolls report, a key read on the labor market that can sway expectations for interest rates. Manufacturing
5 January 2026
···
Argenx stock slides 5% on CEO handover plan — what investors watch next

Argenx stock slides 5% on CEO handover plan — what investors watch next

New York, Jan 5, 2026, 15:30 EST — Regular session Shares of argenx fell about 5% on Monday after the immunology drugmaker said Chief Operating Officer Karen Massey will succeed co-founder Tim Van Hauwermeiren as CEO, with Van Hauwermeiren set to become board chairman pending a shareholder vote on May 6. The stock was down 5% at $797.94 in afternoon trading. argenx The CEO handover matters because argenx is priced like a growth company that still has to prove it can widen its flagship franchise while keeping a costly pipeline on track. Any hint of a change in risk appetite
5 January 2026
····
KLA Corporation stock jumps 6% as chip-equipment rally builds ahead of Nvidia CES keynote

KLA Corporation stock jumps 6% as chip-equipment rally builds ahead of Nvidia CES keynote

New York, Jan 5, 2026, 15:44 EST — Regular session KLA Corp (KLAC.O) shares rose about 6.4% to $1,356 in afternoon trading on Monday, after touching an intraday high of $1,371.82 and setting up for a record closing high. Morningstar The move matters because chip-equipment stocks often act as a real-time gauge of expectations for semiconductor factory spending, which can swing quickly with demand signals. The Philadelphia Semiconductor Index was up about 1% on the day, pointing to a broader bid for the sector rather than a single-stock story. Investors were also positioning ahead of the Consumer Electronics Show (CES),
5 January 2026
·····
Chevron stock jumps 5% on Venezuela shake-up; what investors are watching next

Chevron stock jumps 5% on Venezuela shake-up; what investors are watching next

New York, January 5, 2026, 15:27 ET — Regular session Chevron (CVX) shares were up $8.62, or 5.5%, at $164.52 in afternoon trading, after earlier touching $171.50. The move followed weekend developments in Venezuela and U.S. comments pointing to a push for American oil companies to help rebuild the country’s oil industry, a jolt that lifted the broader energy complex. AP News Chevron is seen as the most direct U.S. beneficiary because it is the only U.S. major still operating in Venezuela under a U.S. waiver — a license that allows limited activity despite sanctions. “This type of crude aligns
5 January 2026
····
Merck stock ticks higher as MRK nears recent highs ahead of JPM Healthcare Conference

Merck stock ticks higher as MRK nears recent highs ahead of JPM Healthcare Conference

New York, January 5, 2026, 15:35 EST — Regular session Merck & Co (NYSE:MRK) shares edged up on Monday as investors looked ahead to the drugmaker’s appearance at the annual J.P. Morgan Healthcare Conference next week. The stock was up 0.3% at $106.80 at 3:35 p.m. EST, after earlier reaching $108.30. The conference is a closely watched early-year marker for healthcare stocks, often offering the first public read on management priorities before earnings season ramps up. Merck’s share performance has also been tied to investor confidence in its longer-term growth story, led by the cancer immunotherapy Keytruda and a broader
5 January 2026
·····
Wall Street’s buyback boom: GM, Southwest and Tapestry headline 2026’s share-repurchase trade

Wall Street’s buyback boom: GM, Southwest and Tapestry headline 2026’s share-repurchase trade

New York, Jan 5, 2026, 15:24 EST General Motors, Southwest Airlines and Tapestry ended 2025 with last-12-month buyback yields above 10% after repurchasing stock worth $8.2 billion, $2.75 billion and $2.8 billion, respectively, MarketBeat wrote on Monday. GM shares rose nearly 53% in 2025, while Southwest gained 23% and Tapestry climbed 96%, the report said. MarketBeat The renewed focus on buybacks comes as investors look for durable supports for equity returns at the start of a new year. Repurchases reduce the number of shares outstanding, which can lift earnings per share even when a company’s overall profit growth slows. That
5 January 2026
·······
Uber stock slips on Melius “Sell” call as robotaxi competition looms in 2026

Uber stock slips on Melius “Sell” call as robotaxi competition looms in 2026

New York, January 5, 2026, 15:27 ET — Regular session Uber Technologies, Inc. shares were down 1.9% at $81.30 in afternoon trading on Monday, after Melius Research downgraded the ride-hailing company to “sell” with a $73 price target. “Even with Uber’s position, AV competition is set to rise in 2026 and beyond,” Melius analyst Conor Cunningham wrote, referring to autonomous vehicles, or self-driving cars. Streetinsider The call is landing at the start of a year when investors are trying to gauge how quickly robotaxis move from pilots into broader commercial service. That matters for Uber because self-driving fleets could change
5 January 2026
····
Bloom Energy stock jumps again as traders refocus on its $600 million credit line

Bloom Energy stock jumps again as traders refocus on its $600 million credit line

New York, January 5, 2026, 15:20 EST — Regular session Bloom Energy shares rose about 5.9% to $104.50 in afternoon trade on Monday as investors weighed the fuel-cell maker’s access to fresh liquidity. The stock hit an intraday high of $107.24. The move matters because financing has become a key swing factor for fast-growing clean-energy companies that still face choppy cash flows. For Bloom, balance-sheet flexibility is under scrutiny as demand builds for on-site power systems tied to data centers and other large electricity users. A revolving credit facility is essentially a bank line of credit that a company can
5 January 2026
·····
Lumentum stock slides 8% as optics peers stumble; investors eye February earnings update

Lumentum stock slides 8% as optics peers stumble; investors eye February earnings update

New York, January 5, 2026, 15:24 EST — Regular session Shares of Lumentum Holdings Inc fell about 7.6% on Monday, extending a selloff across parts of the optical networking space even as the broader U.S. equity market held higher. The slide matters because Lumentum has been one of the standout winners tied to the buildout of AI data centers, leaving little room for disappointment as investors refocus on valuation and the next set of results. Lumentum closed at $386.11 on Friday, close to the 52-week high of $401.60 it hit on Dec. 24, and the stock is up about 326.9%
5 January 2026
········
NewAmsterdam Pharma stock slides on insider sale notices — what investors watch next for NAMS

NewAmsterdam Pharma stock slides on insider sale notices — what investors watch next for NAMS

New York, Jan 5, 2026, 15:21 EST — Regular session Shares of NewAmsterdam Pharma Company N.V. fell about 5% to $33.42 in afternoon trading on Monday. The Nasdaq-listed stock hit an intraday low of $32.68 after opening at $35.15. The move followed two Form 144 filings that signaled planned sales by company affiliates. In smaller biotech names, even routine insider activity can sway short-term sentiment when liquidity is thinner. Form 144 is an SEC notice filed before certain holders sell stock under Rule 144, which governs resales of restricted or “control” shares. The filing does not confirm a sale, but
5 January 2026
····
1 … 912 913 914 915 916 … 2,711

Stock Market Today

Vodafone shares steady up after Q3 wobble — Germany, buyback and next results now set the tone

Vodafone shares steady up after Q3 wobble — Germany, buyback and next results now set the tone

7 February 2026
Vodafone shares rose 1.47% to 110.60p Friday, recovering part of Thursday’s 4.68% drop after a Q3 update. Group revenue climbed 6.5% to €10.5 billion, but Germany’s 0.7% service revenue growth missed some forecasts. Vodafone launched a new €500 million buyback tranche, bringing total buybacks since May to €3.5 billion. Investors remain focused on Germany’s pace and cash flow execution.
NatWest Group stock: buyback filing and Rightmove mortgage deal set up a busy week

NatWest Group stock: buyback filing and Rightmove mortgage deal set up a busy week

7 February 2026
NatWest shares closed up 1.45% at 659.4 pence Friday, buoyed by a buyback of 797,428 shares and a new digital mortgage deal with Rightmove. The Bank of England held rates at 3.75% but signaled possible cuts, with markets pricing in two reductions for 2026. NatWest plans to expand its Accelerator community to 50,000 members by 2026. Annual results are due Feb. 13.
Unilever share price holds at 5,250p as results week looms — what investors watch next

Unilever share price holds at 5,250p as results week looms — what investors watch next

7 February 2026
Unilever shares closed flat at 5,250p in London Friday, underperforming the FTSE 100’s 0.6% gain. The company issued 4.2 million new shares for employee plans, bringing total shares to over 2.18 billion. Investors await Q4 and full-year results on Feb. 12, with analyst consensus pointing to 3.9% Q4 sales growth. Unilever’s U.S. ADR rose 0.8% to $72.12.
BP share price near 52-week high ahead of Feb 10 earnings as buyback runs on

BP share price near 52-week high ahead of Feb 10 earnings as buyback runs on

7 February 2026
BP shares closed up 1.9% at 478 pence Friday, just below a 52-week high, as the company continued buybacks ahead of next week’s results. BP repurchased 2.789 million shares on February 6. Oil prices firmed on geopolitical risk, with Brent at $68.05 a barrel, but sector outlook remains uncertain. Investors await BP’s earnings and dividend decision due Tuesday.
Go toTop